This section defines how computerized systems are identified, scoped, classified, owned, and governed before and during validation. It addresses intended use, GxP impact, software complexity, GAMP 5 principles and categories, supplier assessment, cloud and hosted services, supporting infrastructure, and end-user applications. Emphasis is placed on using system risk, configuration, data criticality, and supplier capability to establish a proportionate lifecycle strategy.
Computerized systems support manufacturing, laboratory, quality, engineering, warehousing, and regulatory processes throughout pharmaceutical operations. They may control equipment, perform calculations, manage workflows, create electronic records, transfer data, or provide information used for product-quality decisions. A computerized system should not be…
GAMP 5 provides a practical, risk-based framework for establishing and maintaining confidence in computerized systems used in regulated pharmaceutical, biotechnology, and medical-device operations. It connects regulatory expectations with lifecycle activities such as intended-use definition, requirements, specification, supplier assessment, configuration, verification,…
GAMP 5 software categories provide a practical way to characterize software components according to how they are developed, configured, and maintained. Categorization helps determine what supplier evidence may be used, which specifications are appropriate, what configuration or code controls are…
Computerized systems used in regulated operations increasingly depend on software developers, cloud providers, implementation partners, infrastructure providers, service organizations, and specialist subcontractors. These suppliers may develop the application, configure workflows, host regulated records, manage infrastructure, perform backups, deploy updates, provide…
Cloud services support quality systems, laboratory operations, manufacturing, data storage, analytics, collaboration, infrastructure, and regulated-record management throughout pharmaceutical and biotechnology organizations. Use of cloud technology does not change the fundamental validation objective. The regulated organization must establish and maintain confidence…
GMP computerized systems depend on technical infrastructure that may not perform the regulated business process directly but can still affect product quality, patient safety, data integrity, record availability, and regulatory compliance. This infrastructure may include physical servers, virtual machines, operating…
Spreadsheets are commonly used for calculations, data analysis, trending, reporting, and recordkeeping in pharmaceutical operations. Other end-user applications include departmental databases, scripts, macros, statistical files, and low-code tools developed outside a formal software-development process. These tools are not automatically GMP…